H.R. 8163: Provider Reimbursement Stability Act of 2026
This bill, known as the Provider Reimbursement Stability Act of 2026, aims to amend Title XVIII of the Social Security Act to enhance the stability and predictability of payment levels for healthcare providers under the Medicare program. Below are the key provisions of the bill:
1. Updating the Budget Neutrality Threshold
The bill proposes to revise the budget neutrality threshold for Medicare payments. Specifically:
- The threshold amount for budget neutrality adjustments will change from $20 million to $54.3 million in 2027, and it will be indexed for subsequent years.
- For years after 2028, the threshold will be adjusted based on the cumulative percentage increase in the Medicare Economic Index (MEI) for physicians' services.
2. Corrections Related to Estimated Utilization
This provision establishes a process for correcting budget neutrality adjustments based on the actual usage of healthcare services:
- Starting in 2027, if there is a significant difference between the estimated and actual utilization of specified services, adjustments will be made to the Medicare payment conversion factor to reconcile discrepancies.
- This ensures that Medicare payments reflect actual service usage rather than just estimates.
3. Nonapplication of Budget Neutrality to Certain Adjustments
The bill also specifies that certain adjustments related to budget neutrality will not apply during correction periods. This is to prevent the negative impact on payments due to incorrect estimates from previous years.
4. Timely Updates to Direct Costs
The Secretary of Health and Human Services will be required to update key direct costs used to calculate practice expense relative value units (RVUs) at least once every five years. The updates will include aspects like:
- Clinical staff wage rates
- Prices of medical supplies
- Prices of equipment
Consultation with healthcare stakeholders will also be mandated during this updating process.
5. Limitation on Year-to-Year Conversion Factor Variance
The bill establishes a cap on how much Medicare payment rates (conversion factors) can fluctuate each year due to budget neutrality adjustments:
- Starting in 2027, these adjustments cannot vary by more than 2.5% from the previous year's conversion factor, which adds a layer of payment certainty for providers.
- The requirement for budget neutrality will still remain in effect.
Overall Objective
The main goal of this legislation is to provide more predictable and stable reimbursement for Medicare providers, aiming to reflect actual costs and usage more accurately.
Relevant Companies
- VRX (Valeant Pharmaceuticals): As a pharmaceutical company, Valeant could be impacted by changes in Medicare reimbursements for drugs.
- UNH (UnitedHealth Group): UnitedHealth, being a major insurer, may need to adjust its payment structures based on changes in Medicare payment rates to healthcare providers.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
34 bill sponsors
-
TrackGregory F. Murphy
Sponsor
-
TrackBrian Babin
Co-Sponsor
-
TrackJoyce Beatty
Co-Sponsor
-
TrackBrendan F. Boyle
Co-Sponsor
-
TrackSalud O. Carbajal
Co-Sponsor
-
TrackHerbert Conaway
Co-Sponsor
-
TrackDonald G. Davis
Co-Sponsor
-
TrackNeal P. Dunn
Co-Sponsor
-
TrackBrian K. Fitzpatrick
Co-Sponsor
-
TrackDaniel S. Goldman
Co-Sponsor
-
TrackVicente Gonzalez
Co-Sponsor
-
TrackAl Green
Co-Sponsor
-
TrackJulie Johnson
Co-Sponsor
-
TrackJohn Joyce
Co-Sponsor
-
TrackRobin L. Kelly
Co-Sponsor
-
TrackRaja Krishnamoorthi
Co-Sponsor
-
TrackTed Lieu
Co-Sponsor
-
TrackDaniel Meuser
Co-Sponsor
-
TrackMax L. Miller
Co-Sponsor
-
TrackCarol D. Miller
Co-Sponsor
-
TrackMariannette Miller-Meeks
Co-Sponsor
-
TrackGwen Moore
Co-Sponsor
-
TrackRobert Onder
Co-Sponsor
-
TrackJimmy Panetta
Co-Sponsor
-
TrackBradley Scott Schneider
Co-Sponsor
-
TrackHillary J. Scholten
Co-Sponsor
-
TrackKim Schrier
Co-Sponsor
-
TrackDavid Scott
Co-Sponsor
-
TrackTerri A. Sewell
Co-Sponsor
-
TrackLloyd Smucker
Co-Sponsor
-
TrackThomas R. Suozzi
Co-Sponsor
-
TrackClaudia Tenney
Co-Sponsor
-
TrackGlenn Thompson
Co-Sponsor
-
TrackDina Titus
Co-Sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Mar. 30, 2026 | Introduced in House |
| Mar. 30, 2026 | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
